These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 11408034

  • 1. Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues.
    Di Marzo V, Lastres-Becker I, Bisogno T, De Petrocellis L, Milone A, Davis JB, Fernandez-Ruiz JJ.
    Eur J Pharmacol; 2001 May 25; 420(2-3):123-31. PubMed ID: 11408034
    [Abstract] [Full Text] [Related]

  • 2. Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide.
    Di Marzo V, Breivogel C, Bisogno T, Melck D, Patrick G, Tao Q, Szallasi A, Razdan RK, Martin BR.
    Eur J Pharmacol; 2000 Oct 20; 406(3):363-74. PubMed ID: 11040343
    [Abstract] [Full Text] [Related]

  • 3. A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid.
    Di Marzo V, Griffin G, De Petrocellis L, Brandi I, Bisogno T, Williams W, Grier MC, Kulasegram S, Mahadevan A, Razdan RK, Martin BR.
    J Pharmacol Exp Ther; 2002 Mar 20; 300(3):984-91. PubMed ID: 11861807
    [Abstract] [Full Text] [Related]

  • 4. Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors.
    Melck D, Bisogno T, De Petrocellis L, Chuang H, Julius D, Bifulco M, Di Marzo V.
    Biochem Biophys Res Commun; 1999 Aug 19; 262(1):275-84. PubMed ID: 10448105
    [Abstract] [Full Text] [Related]

  • 5. Involvement of vanilloid-like receptors in the effects of anandamide on motor behavior and nigrostriatal dopaminergic activity: in vivo and in vitro evidence.
    de Lago E, de Miguel R, Lastres-Becker I, Ramos JA, Fernández-Ruiz J.
    Brain Res; 2004 May 08; 1007(1-2):152-9. PubMed ID: 15064146
    [Abstract] [Full Text] [Related]

  • 6. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity.
    De Petrocellis L, Bisogno T, Davis JB, Pertwee RG, Di Marzo V.
    FEBS Lett; 2000 Oct 13; 483(1):52-6. PubMed ID: 11033355
    [Abstract] [Full Text] [Related]

  • 7. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
    Golech SA, McCarron RM, Chen Y, Bembry J, Lenz F, Mechoulam R, Shohami E, Spatz M.
    Brain Res Mol Brain Res; 2004 Dec 06; 132(1):87-92. PubMed ID: 15548432
    [Abstract] [Full Text] [Related]

  • 8. Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens.
    Ross RA, Gibson TM, Brockie HC, Leslie M, Pashmi G, Craib SJ, Di Marzo V, Pertwee RG.
    Br J Pharmacol; 2001 Feb 06; 132(3):631-40. PubMed ID: 11159715
    [Abstract] [Full Text] [Related]

  • 9. Anandamide and methanandamide induce both vanilloid VR1- and cannabinoid CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats.
    Malinowska B, Kwolek G, Göthert M.
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Dec 06; 364(6):562-9. PubMed ID: 11770012
    [Abstract] [Full Text] [Related]

  • 10. Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases.
    Veldhuis WB, van der Stelt M, Wadman MW, van Zadelhoff G, Maccarrone M, Fezza F, Veldink GA, Vliegenthart JF, Bär PR, Nicolay K, Di Marzo V.
    J Neurosci; 2003 May 15; 23(10):4127-33. PubMed ID: 12764100
    [Abstract] [Full Text] [Related]

  • 11. Endocannabinoids induce ileitis in rats via the capsaicin receptor (VR1).
    McVey DC, Schmid PC, Schmid HH, Vigna SR.
    J Pharmacol Exp Ther; 2003 Feb 15; 304(2):713-22. PubMed ID: 12538826
    [Abstract] [Full Text] [Related]

  • 12. Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB(1)/CB(2) receptors.
    Brooks JW, Pryce G, Bisogno T, Jaggar SI, Hankey DJ, Brown P, Bridges D, Ledent C, Bifulco M, Rice AS, Di Marzo V, Baker D.
    Eur J Pharmacol; 2002 Mar 29; 439(1-3):83-92. PubMed ID: 11937096
    [Abstract] [Full Text] [Related]

  • 13. Temperature-dependent activation of recombinant rat vanilloid VR1 receptors expressed in HEK293 cells by capsaicin and anandamide.
    Sprague J, Harrison C, Rowbotham DJ, Smart D, Lambert DG.
    Eur J Pharmacol; 2001 Jul 06; 423(2-3):121-5. PubMed ID: 11448475
    [Abstract] [Full Text] [Related]

  • 14. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide.
    Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sørgård M, Di Marzo V, Julius D, Högestätt ED.
    Nature; 1999 Jul 29; 400(6743):452-7. PubMed ID: 10440374
    [Abstract] [Full Text] [Related]

  • 15. Comparison of effects of anandamide at recombinant and endogenous rat vanilloid receptors.
    Jerman JC, Gray J, Brough SJ, Ooi L, Owen D, Davis JB, Smart D.
    Br J Anaesth; 2002 Dec 29; 89(6):882-7. PubMed ID: 12453933
    [Abstract] [Full Text] [Related]

  • 16. Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro.
    Ahluwalia J, Urban L, Bevan S, Nagy I.
    Eur J Neurosci; 2003 Jun 29; 17(12):2611-8. PubMed ID: 12823468
    [Abstract] [Full Text] [Related]

  • 17. Hypotensive effect of anandamide through the activation of CB1 and VR1 spinal receptors in urethane-anesthetized rats.
    del Carmen García M, Adler-Graschinsky E, Celuch SM.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Oct 29; 368(4):270-6. PubMed ID: 14504685
    [Abstract] [Full Text] [Related]

  • 18. Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease.
    Lastres-Becker I, de Miguel R, De Petrocellis L, Makriyannis A, Di Marzo V, Fernández-Ruiz J.
    J Neurochem; 2003 Mar 29; 84(5):1097-109. PubMed ID: 12603833
    [Abstract] [Full Text] [Related]

  • 19. Dual effect of cannabinoid CB1 receptor stimulation on a vanilloid VR1 receptor-mediated response.
    Hermann H, De Petrocellis L, Bisogno T, Schiano Moriello A, Lutz B, Di Marzo V.
    Cell Mol Life Sci; 2003 Mar 29; 60(3):607-16. PubMed ID: 12737320
    [Abstract] [Full Text] [Related]

  • 20. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.
    Gómez R, Navarro M, Ferrer B, Trigo JM, Bilbao A, Del Arco I, Cippitelli A, Nava F, Piomelli D, Rodríguez de Fonseca F.
    J Neurosci; 2002 Nov 01; 22(21):9612-7. PubMed ID: 12417686
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.